AstraZeneca Gets CDSCO Panel Nod To study Tezepelumab Dr. Divya Colin13 April 2025 5:30 PM ISTNew Delhi: Pharmaceutical major AstraZeneca Pharma India has got approval from the Subject Expert Committee (SEC) functional under the Central Drug...
US tariffs on pharma sector would be counterproductive for Americans, says Wockhardt Chairman Ruchika Sharma13 April 2025 3:15 PM ISTWockhardt Chairman Habib Khorakiwala said that U.S. tariffs on pharmaceutical products would ultimately be counterproductive for Americans.The U.S....
Novartis plans to invest USD 23 billion over next 5 years in US based infrastructure Ruchika Sharma13 April 2025 12:30 PM ISTEast Hanover: Novartis, a global medicines company, has announced a planned USD 23 billion investment over 5 years in US-based infrastructure,...
Pomalyst monopoly case: Bristol Myers wins dismissal of lawsuit Ruchika Sharma13 April 2025 11:00 AM ISTA federal judge in New York has dismissed a proposed class action against pharmaceutical giant Bristol Myers Squibb, which accused the company of...
Morepen Labs plans to employ over 1000 professionals Ruchika Sharma12 April 2025 1:52 PM ISTGurugram: Morepen Laboratories Ltd. has announced the addition of more than 1,000 professionals to its salesforce over the next three years,...
Raid at quack clinic in Telangana, drugs including Amoxycillin seized Ruchika Sharma12 April 2025 12:33 PM ISTTelangana: Drugs Control Administration, Telangana raided a quack's clinic in Medaram Village, Tadvai Mandal, Mulugu District and seized drugs...
Zydus Lifesciences bags USFDA nod for Duchenne muscular dystrophy drug Jaythari Ruchika Sharma12 April 2025 11:30 AM ISTAhmedabad: Pharma major, Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration (USFDA)...
Johnson & Johnson gets CDSCO Panel for additional indication of Amivantamab Liquid Concentrate for Infusion Dr. Divya Colin12 April 2025 5:45 AM ISTNew Delhi: In a significant development, the drug major Johnson and Johnson has got the go-ahead from the Subject Expert Committee (SEC) functional...
Submit Phase III CT data with Pk and Pd data: CDSCO Panel Tells Intas Pharmaceuticals on Human von Willebrand Factor Dr. Divya Colin12 April 2025 5:30 AM ISTNew Delhi: In response to the proposal for the grant of permission to manufacture Human von Willebrand Factor EP 600 IU (Freeze Dried Powder) Drug...
Aurobindo Pharma arm gets 11 USFDA observations for Raleigh Plant Ruchika Sharma11 April 2025 5:46 PM ISTHyderabad: Aurobindo Pharma has announced that the United States Food and Drug Administration (USFDA) has issued 11 observations after an...
Pharma Scam worth Rs 10 Cr in Ludhiana: Company Employees Booked for Massive Internal Fraud Farhat Nasim11 April 2025 4:16 PM ISTLudhiana: A major pharmaceutical company located in Ludhiana's Industrial Area A has become the latest victim of internal financial fraud, with losses...
USFDA plans to phase out animal testing requirement for monoclonal antibodies, other drugs Ruchika Sharma11 April 2025 4:08 PM ISTIn a significant move toward modernizing drug development, the U.S. Food and Drug Administration (USFDA) has announced plans to phase out its...
